Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function

NCT01812447
terminatednot_applicable

Spiration Valves Against Standard Therapy

NCT02382614
completednot_applicable

REACH SVS Control Patient Cross-Over Study

NCT02914340
completednot_applicable

The Spiration Valve System for the Treatment of Severe Emphysema

NCT01989182

Clinical Trials (4)

Showing 4 of 4 trials
NCT01812447Not Applicable

Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function

Completed
NCT02382614Not Applicable

Spiration Valves Against Standard Therapy

Terminated
NCT02914340Not Applicable

REACH SVS Control Patient Cross-Over Study

Completed
NCT01989182Not Applicable

The Spiration Valve System for the Treatment of Severe Emphysema

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4